LFG
PHAR

Larson Financial Group’s Pharming Group PHAR Stock Holding History

Larson Financial Group’s Portfolio PHAR Stock Details PHAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97 Sell
7
-336
-98% -$4.87K ﹤0.01% 3653
2026
Q1 		$5.71K Buy
+343
New +$5.82K ﹤0.01% 2536

Other funds holding PHAR

MACM
MAC Alpha Capital Management Tampa, Florida $216M AUM
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
SGFG
Silver Grove Financial Group Orchard Park, New York $185M AUM 28.01% 1-Year Est. Return
NSG
Nalls Sherbakoff Group Knoxville, Tennessee $141M AUM 25.05% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM

Larson Financial Group's PHAR Position: Q2 2026 in Review

Larson Financial Group reduced its Pharming Group (PHAR) stake by 98% in Q2 2026, selling an estimated $4.87K and leaving 7 shares worth $97. The position accounts for ﹤0.01% of the portfolio, ranked #3653.

Larson Financial Group first reported a position in PHAR in Q1 2026 and has held it in 2 quarters since. The position peaked at $5.71K in Q1 2026. 17 funds tracked by Wall St. Rank hold PHAR as of Q2 2026.

  • Larson Financial Group held 7 shares of Pharming Group worth $97 as of Q2 2026.
  • Larson Financial Group sold 336 Pharming Group shares in Q2 2026, an estimated $4.87K.
  • Pharming Group made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3653 holding.
  • Larson Financial Group first reported a position in Pharming Group in Q1 2026 and has held it in 2 quarters since.
  • Larson Financial Group's Pharming Group position peaked at $5.71K in Q1 2026.
  • 17 funds tracked by Wall St. Rank held Pharming Group as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.